For our edutainment today we’re sniffing out the solution to the latest teaser ad from the Oxford Club — Steve McDonald, one of their analysts, spins a long story about cybersecurity that reminds us of several other past ditigal security teasers. Not that there’s anything wrong with that — this is, by all accounts, one […]
Articles
- Most Relevant
- Most Recent
This week there’s been quite a bit of news in stocks that I follow fairly closely or own or have featured in the past as “Idea of the Month” candidates for the irregulars, so I do have a bit of a teaser campaign to talk to you about (that’s the Casey bit), but I’m going […]
This delightful ad has clearly graced many an inbox over the past few days — I know I’ve gotten it about a dozen times myself, not to mention the hundreds of Gumshoe readers who have also been kind enough to send it along. OK, dozens. Still. So the marketing push is on … … but, […]
Weekly escalations in nuclear threats, record-breaking hurricanes… what is it going to take to shake investor sentiment for more than 24 hours? The S&P 500 is ending the week only down about a third of one percent, gold is up less than 2%, this is a market that is reacting to headlines pretty quickly… but […]
Thank you for coming back and reading my musings week after week, we here at Stock Gumshoe would not exist if not for the attention and generosity of readers like you. I don’t say it enough, I’m sure, but I really appreciate you being with us… and having the patience to slog through these sometimes […]
The Amissio Forumula ReviewedThe Amissio Formula Review: In this review of Craig Phillips’ Amissio Forumula software we will reveal our test results that prove itās a scam! Our Official Amissio Forumula System Review About The Amissio Forumula Software: Product Name: The Amissio Forumula Niche: Binary Option Trading Software Price: Free Product Creator: Craig Phillips Product Summary: The Amissio […]
Akamai is a Hawaiian word that means “smart” or “clever” — not an accident for an MIT-born firm that has been supplying the business backbone to parts of the web for many years, even though most people (myself included) don’t really understand everything that they do. I’ve owned Akamai a couple times over the years […]
Whitney Tilson sold his presentation big this year, saying he had put together a Einhorn-esque slide deck of 120 pages with a short argument about K12 (LRN). On shorts in general, he said he has done awfully with shorts for a few years — but he sees a world that is so target-rich with crazy, […]
And our Annual Review proceeds apace… on a day when the market is showing signs of actually having a meaningful correction, thanks to Friday jitters and inflation worries and rising interest rates… so cross your fingers for better prices in the week to come (I did buy a couple positions this week, but as I […]
I’ll be traveling this weekend, so I’m getting your Friday File out to you a bit early this week — I want to take a look at a couple of developments in the “Gumshoe Universe” of stocks and see if I want to change my mind about any of these companies. I also have a […]
Awesome Income App Review: In this review of Travis Gold’s the Awesome Income App (as featured on awesomeincomeapp.com) we will reveal our test results that prove itās a scam! Our Official Awesome Income App Review About the Travis Gold’s Awesome Income App: Product Name: Awesome Income App Niche: Binary Option Trading Software Price: Free Product […]
Everyone in the investing punditry game has to make predictions, so I’ll go out on a limb here and let you know which of the stocks in the Gumshoe universe I’m most excited about for the coming year. I’m also, so you know, going to be revamping how I present and track the “Idea of […]
Akamai is a Hawaiian word that means “smart” or “clever” — not an accident for an MIT-born firm that has been supplying the business backbone to parts of the web for many years, even though most people (myself included) don’t really understand everything that they do. I’ve owned Akamai a couple times over the years […]
[ed. note: Michael Jorrin, who I like to call Doc Gumshoe, is a longtime medical writer (not a doctor) who writes about non-financial health and medical issues for us a couple times a month — this time, he’s covering one of the many over-hyped health ads for “secret” supplements and treatments that we all see […]
Over time, I will try to collect past posts on these topics and collect them here. I’ll try to get the original posters and dates, although some are missing in this first post. JIN SHIN JYUTSU POSTS BY REBS (formerly Roger) Roger – At 87 I do Qigong, 8 brocades, Yang 10, 24, 48, 42, […]
I’ve got a handful of updates for you, including one on a stock that I bought yesterday and a few other notes about recent quarterly reports from stocks I follow, but first … a teaser to solve … When I wrote about Marc Lichtenfeld’s pitch for “Spread Trusts” yesterday, I promised to also try to […]
In light of a interview I watched tonight of Steve Sjuggerudās forecast on the Yuan becoming the next IMR, I found some challenges to Steveās interview and would like a comment or rebuttal. These challenges were in the Wall Street Journal: āTo be sure, even if the yuan is recognized by the IMF as a […]
The Value Investing Congress is always an interesting place to hear about ideas and strategies from some of the better money managers and analysts around, but I’m finding it particularly valuable this year … when the market is going through crazy gyrations and moving up and down on macro news like European debt or unemployment […]
The Value Investing Congress is always an interesting place to hear about ideas and strategies from some of the better money managers and analysts around, but I’m finding it particularly valuable this year … when the market is going through crazy gyrations and moving up and down on macro news like European debt or unemployment […]
This time around I thought I’d get into some more detail for you on a stock I’ve written about before, and which I own personally — but I think it’s underappreciated given its potential for inflation protection and dividend growth. April’s Idea of the Month is shares of Retail Opportunity Investments Corp (ROIC). That ROIC […]
Proven Profits Review: In this review of Matt Baker’s Proven Profit’s software we will reveal our test results that prove itās a scam! Our Official Proven Profits Software Review About The Proven Profits Software: Product Name: Proven Profits Niche: Binary Option Trading Software Price: Free Product Creator: Matt Baker Product Summary: Proven Profits is a […]
Awesome Income App Review: In this review of Travis Gold’s the Awesome Income App (as featured on awesomeincomeapp.com) we will reveal our test results that prove itās a scam! Our Official Awesome Income App Review About the Travis Gold’s Awesome Income App: Product Name: Awesome Income App Niche: Binary Option Trading Software Price: Free Product […]
7 Figure Club Review: In this review of Martin Taylor’s 7 Figure Club software (as featured on 7figureclub.co) we will reveal our test results that prove itās a scam! Our Official 7 Figure Club Review About the 7 Figure Club Software: Product Name: 7 Figure Club Niche: Binary Option Trading Software Price: Free Product Creator: […]
This is the first ticker specific discussionā¦..if it works, there may be many others. The aim is to have a chronological knowledge diary. If your comment is about ANYTHING other than $ARTHā¦please DONT post it here. **Please note that this post has been closed to further comment. The discussion on ARTH has moved over to […]
I haven’t written about a Christian DeHaemer pitch in a while, so this one popped to the top of our list today when a few readers asked about it. And part of the pitch is similar to others we’ve seen about the “death of cable” — all about the cord cutters, and about the fact […]
Ian Wyatt has teased “venture capital” style investments before for his Million Dollar Portfolio newsletter, but this one has at least one name that hasn’t popped up before… so I thought I’d take a look for you. (And from what I can tell it used to be the $100K portfolio, so I guess he’s doing […]
We’ve got a quickie here that a few folks asked about, and I thought I’d throw it out for you just because there are so many of you who are interested in biotech stocks (and why wouldn’t you be, of course, given the fact that the biotech index would have given you a 350%+ return […]
In light of a interview I watched tonight of Steve Sjuggerudās forecast on the Yuan becoming the next IMR, I found some challenges to Steveās interview and would like a comment or rebuttal. These challenges were in the Wall Street Journal: āTo be sure, even if the yuan is recognized by the IMF as a […]
We’ve had a number of questions about this pitch for “The Next Chipotle” from Briton Ryle, so we’re re-posting this solution from December — the stock they’re teasing, ZOES, is still the same, though it reported a great first quarter in early June and the shares popped up on the news (and came back down […]
This article was originally published in late January — Andy Obermueller is teasing Apple suppliers again, hinting that the Apple “Growth Window” will close up on September 30 (presumably when we start freaking out about their next wave of iPhones and iPads, usually introduced around then), and the descriptions of the teased stocks that he […]
Yesterday we looked at Louis Navellier’s pitch about his “bulletproof” stocks to buy — mostly pretty reasonable growth stocks that are priced like growth stocks, but not the crazy hyper-momentum valuations that scare people. Today I thought we’d take a quick moment to ID a couple of the other ideas in his ad. The big […]
We continue to see worrisome commentary about market valuations, with hand-wringing about whether the stock market is overvalued or might be in a bubble… and it can get a bit draining, frankly. Caution is important, diversification is important, but worrying does us little good. Yes, investors are paying a steep price for anticipated growth in […]
Lots of folks are asking about this one, so we’re pulling it to the top of the page again — the article below has not been updated or revised since it ran on March 10, though in the interim the stock teased bumped from $10 to $13 and is now back down below $12, with […]
Earlier this week, when I was looking into Teeka Tiwari’s pitch about stealing from Vladimir Putin, I promised that I’d follow up and look at the gold investment he was also teasing in that letter… so let’s get to it! His overall spiel is selling something he calls the “New Cold War Playbook” as a […]
A new study Push Telecommunications for Tele-Medicine (PTT) and M-Health: Market Shares, Strategy, and Forecasts, Worldwide, 2015 to 2021. The 2015 study has 815 pages, 259 tables and figures. Worldwide markets are poised to achieve significant growth as the push systems are used inside telemedicine systems and m-health apps to move patient and clinician communication […]
This article is a repeat of a solution to a teaser pitch that Dr. Kent Moors has been marketing very aggressively for almost a year. Why? Because he and his publishers at Money Map are pushing it very heavily again, as they’ve done every few months, and we’re getting questions… and there have been some […]
This microblog is not for a discussion of stocks – it’s for telling fellow Gummies and Gummie-esses about WEB SITES THAT HAVE SOMETHING TO DO WITH INVESTING that you find useful. To start with, http://www.macrotrends.net/ has 60 historical charts ranging from topics like ā¦..A Gold to Oil Ratio Historical Chart ā¦.tracks the ratio of the […]
This microblog is for stocks that do not fit neatly in http://www.stockgumshoe.com/2015/04/microblog-biotech-in-a-dr-kss-less-world/ or http://www.stockgumshoe.com/2015/04/microblog-biotech-by-hendrixnuzzles/. To get started, Thomas Kelly mentioned NVIV on the āā¦ā¦by-hendrixnuzzles blog ā: āā¦. The Neuro-Spinal Scaffold is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord contusion. The Neuro-Spinal Scaffold provides […]
BIOTECH IN A Dr. KSS-LESS WORLD Welcome! The purpose of this thread will be to discuss, identify and follow small or mid-cap biotechs that have credible scientific platforms , big potential target markets, favorable qualified second party medical opinion, and significant stock appreciation potential in a one-to-three year time horizon; and to create and track […]
This thread is designed to allow Irregulars to discuss, share and provide input for calender catalyst events, primarily but not limited to equities contained on the Green Tab of the KSS Da Man! spreadsheet that is maintained by Hi Pockets. The calender currently can be updated only by Benny, Lawrence, Dr. KSS and myself. The […]